Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis.

@article{Oliveira2003NonspecificCI,
  title={Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis.},
  author={Walmar Roncalli Pereira de Oliveira and Solange Carrasco and Cyro Festa Neto and Peter L. Rady and Stephen K Tyring},
  journal={The Journal of dermatology},
  year={2003},
  volume={30 3},
  pages={203-9}
}
Epidermodysplasia verruciformis (EV) is a rare disease that usually begins in childhood and is characterized by a generalized infection by human papilloma virus (HPV), frequent associations with cutaneous carcinomas, and abnormalities of cell-mediated immunity (CMI). We studied nonspecific CMI in 13 patients with EV by bacterial skin tests, allergic reactions to dinitrochlorobenzene (DNCB), measurement of responses to phytohemagglutinin (PHA), and quantification of T lymphocytes and T… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Epidermodysplasia verruciformis associated with isolated IgM deficiency.

Indian journal of dermatology, venereology and leprology • 2007
View 4 Excerpts
Highly Influenced

Epidermodysplasia verruciformis.

Current problems in dermatology • 2014

Acquired epidermodysplasia verruciformis: a comprehensive review and a proposal for treatment.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] • 2013
View 1 Excerpt

Similar Papers

Loading similar papers…